Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producingadvanced gastric neuroendocrine carcinoma

Nobuhiro Tsuruta, Kotoe Takayoshi, Shuji Arita, Tomomi Aikawa, hiroshi ariyama, Hitoshi Kusaba, Kenoki Ouchida, Eishi Nagai, Kenichi Kouhashi, Minako Hirahashi, Kyoko Inadomi, Mamoru Tanaka, Kosuke Sagara, Yuta Okumura, Kenta Nio, Michitaka Nakano, Masafumi Nakamura, Yoshinao Oda, Koichi Akashi, Eishi Baba

研究成果: ジャーナルへの寄稿記事

抄録

An advanced granulocyte-colony stimulating factor (G-CSF)-producing tumor is rare, and it exhibits leukocytosis in association with high serum G-CSF levels. A 67-year-old male with a 1-month history of bloody emesis and black stools was revealed to exhibit leukocytosis, anemia and a high serum concentration of G-CSF. During a gastrointestinal endoscopy, an ulcerating tumor was identified in the stomach. Computed tomography and a fluorodeoxyglucose-positron emission tomography scan demonstrated direct invasion of the gastric tumor into the transverse colon, regional lymphadenopathy, lung nodules and diffuse high uptake of FDG in bone marrow. The histological diagnosis was a G-CSF-producing neuroendocrine carcinoma (NEC) (tumor 4b, node 2, metastasis 1, pulmonary, clinical stage IV). Systemic chemotherapy consisting of cisplatin and irinotecan was started. Common terminology criteria of adverse events grade 3 tumor lysis syndrome and gastric penetration appeared. Grade 4 neutropenia lasted for 10 days despite intensive G-CSF administration. Prominent shrinkage of the primary and the metastatic tumors was observed subsequent to 3 cycles of chemotherapy. Total gastrectomy and resection of the transverse colon were subsequently performed. Systemic chemotherapy was effective for a G-CSF-producing advanced gastric NEC with careful monitoring and appropriate supportive care for severe adverse events.

元の言語英語
ページ(範囲)1500-1504
ページ数5
ジャーナルOncology Letters
14
発行部数2
DOI
出版物ステータス出版済み - 1 1 2017

Fingerprint

Neuroendocrine Carcinoma
Granulocyte Colony-Stimulating Factor
Neutropenia
Stomach
Drug Therapy
Transverse Colon
irinotecan
Leukocytosis
Neoplasms
Tumor Lysis Syndrome
Lung
Gastrointestinal Endoscopy
Neuroendocrine Tumors
Gastrectomy
Serum
Terminology
Positron-Emission Tomography
Cisplatin
Vomiting
Anemia

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producingadvanced gastric neuroendocrine carcinoma. / Tsuruta, Nobuhiro; Takayoshi, Kotoe; Arita, Shuji; Aikawa, Tomomi; ariyama, hiroshi; Kusaba, Hitoshi; Ouchida, Kenoki; Nagai, Eishi; Kouhashi, Kenichi; Hirahashi, Minako; Inadomi, Kyoko; Tanaka, Mamoru; Sagara, Kosuke; Okumura, Yuta; Nio, Kenta; Nakano, Michitaka; Nakamura, Masafumi; Oda, Yoshinao; Akashi, Koichi; Baba, Eishi.

:: Oncology Letters, 巻 14, 番号 2, 01.01.2017, p. 1500-1504.

研究成果: ジャーナルへの寄稿記事

Tsuruta, Nobuhiro ; Takayoshi, Kotoe ; Arita, Shuji ; Aikawa, Tomomi ; ariyama, hiroshi ; Kusaba, Hitoshi ; Ouchida, Kenoki ; Nagai, Eishi ; Kouhashi, Kenichi ; Hirahashi, Minako ; Inadomi, Kyoko ; Tanaka, Mamoru ; Sagara, Kosuke ; Okumura, Yuta ; Nio, Kenta ; Nakano, Michitaka ; Nakamura, Masafumi ; Oda, Yoshinao ; Akashi, Koichi ; Baba, Eishi. / Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producingadvanced gastric neuroendocrine carcinoma. :: Oncology Letters. 2017 ; 巻 14, 番号 2. pp. 1500-1504.
@article{68883994b13d4879a4adf3e2011824e1,
title = "Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producingadvanced gastric neuroendocrine carcinoma",
abstract = "An advanced granulocyte-colony stimulating factor (G-CSF)-producing tumor is rare, and it exhibits leukocytosis in association with high serum G-CSF levels. A 67-year-old male with a 1-month history of bloody emesis and black stools was revealed to exhibit leukocytosis, anemia and a high serum concentration of G-CSF. During a gastrointestinal endoscopy, an ulcerating tumor was identified in the stomach. Computed tomography and a fluorodeoxyglucose-positron emission tomography scan demonstrated direct invasion of the gastric tumor into the transverse colon, regional lymphadenopathy, lung nodules and diffuse high uptake of FDG in bone marrow. The histological diagnosis was a G-CSF-producing neuroendocrine carcinoma (NEC) (tumor 4b, node 2, metastasis 1, pulmonary, clinical stage IV). Systemic chemotherapy consisting of cisplatin and irinotecan was started. Common terminology criteria of adverse events grade 3 tumor lysis syndrome and gastric penetration appeared. Grade 4 neutropenia lasted for 10 days despite intensive G-CSF administration. Prominent shrinkage of the primary and the metastatic tumors was observed subsequent to 3 cycles of chemotherapy. Total gastrectomy and resection of the transverse colon were subsequently performed. Systemic chemotherapy was effective for a G-CSF-producing advanced gastric NEC with careful monitoring and appropriate supportive care for severe adverse events.",
author = "Nobuhiro Tsuruta and Kotoe Takayoshi and Shuji Arita and Tomomi Aikawa and hiroshi ariyama and Hitoshi Kusaba and Kenoki Ouchida and Eishi Nagai and Kenichi Kouhashi and Minako Hirahashi and Kyoko Inadomi and Mamoru Tanaka and Kosuke Sagara and Yuta Okumura and Kenta Nio and Michitaka Nakano and Masafumi Nakamura and Yoshinao Oda and Koichi Akashi and Eishi Baba",
year = "2017",
month = "1",
day = "1",
doi = "10.3892/ol.2017.6299",
language = "English",
volume = "14",
pages = "1500--1504",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producingadvanced gastric neuroendocrine carcinoma

AU - Tsuruta, Nobuhiro

AU - Takayoshi, Kotoe

AU - Arita, Shuji

AU - Aikawa, Tomomi

AU - ariyama, hiroshi

AU - Kusaba, Hitoshi

AU - Ouchida, Kenoki

AU - Nagai, Eishi

AU - Kouhashi, Kenichi

AU - Hirahashi, Minako

AU - Inadomi, Kyoko

AU - Tanaka, Mamoru

AU - Sagara, Kosuke

AU - Okumura, Yuta

AU - Nio, Kenta

AU - Nakano, Michitaka

AU - Nakamura, Masafumi

AU - Oda, Yoshinao

AU - Akashi, Koichi

AU - Baba, Eishi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - An advanced granulocyte-colony stimulating factor (G-CSF)-producing tumor is rare, and it exhibits leukocytosis in association with high serum G-CSF levels. A 67-year-old male with a 1-month history of bloody emesis and black stools was revealed to exhibit leukocytosis, anemia and a high serum concentration of G-CSF. During a gastrointestinal endoscopy, an ulcerating tumor was identified in the stomach. Computed tomography and a fluorodeoxyglucose-positron emission tomography scan demonstrated direct invasion of the gastric tumor into the transverse colon, regional lymphadenopathy, lung nodules and diffuse high uptake of FDG in bone marrow. The histological diagnosis was a G-CSF-producing neuroendocrine carcinoma (NEC) (tumor 4b, node 2, metastasis 1, pulmonary, clinical stage IV). Systemic chemotherapy consisting of cisplatin and irinotecan was started. Common terminology criteria of adverse events grade 3 tumor lysis syndrome and gastric penetration appeared. Grade 4 neutropenia lasted for 10 days despite intensive G-CSF administration. Prominent shrinkage of the primary and the metastatic tumors was observed subsequent to 3 cycles of chemotherapy. Total gastrectomy and resection of the transverse colon were subsequently performed. Systemic chemotherapy was effective for a G-CSF-producing advanced gastric NEC with careful monitoring and appropriate supportive care for severe adverse events.

AB - An advanced granulocyte-colony stimulating factor (G-CSF)-producing tumor is rare, and it exhibits leukocytosis in association with high serum G-CSF levels. A 67-year-old male with a 1-month history of bloody emesis and black stools was revealed to exhibit leukocytosis, anemia and a high serum concentration of G-CSF. During a gastrointestinal endoscopy, an ulcerating tumor was identified in the stomach. Computed tomography and a fluorodeoxyglucose-positron emission tomography scan demonstrated direct invasion of the gastric tumor into the transverse colon, regional lymphadenopathy, lung nodules and diffuse high uptake of FDG in bone marrow. The histological diagnosis was a G-CSF-producing neuroendocrine carcinoma (NEC) (tumor 4b, node 2, metastasis 1, pulmonary, clinical stage IV). Systemic chemotherapy consisting of cisplatin and irinotecan was started. Common terminology criteria of adverse events grade 3 tumor lysis syndrome and gastric penetration appeared. Grade 4 neutropenia lasted for 10 days despite intensive G-CSF administration. Prominent shrinkage of the primary and the metastatic tumors was observed subsequent to 3 cycles of chemotherapy. Total gastrectomy and resection of the transverse colon were subsequently performed. Systemic chemotherapy was effective for a G-CSF-producing advanced gastric NEC with careful monitoring and appropriate supportive care for severe adverse events.

UR - http://www.scopus.com/inward/record.url?scp=85021768704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021768704&partnerID=8YFLogxK

U2 - 10.3892/ol.2017.6299

DO - 10.3892/ol.2017.6299

M3 - Article

VL - 14

SP - 1500

EP - 1504

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 2

ER -